WND By Art Moore
Biden’s FDA circumventing doctors to prescribe ineffective drug
The Pfizer drug that caused a rebound of symptoms when quadruple-vaccinated Dr. Anthony Fauci contracted COVID-19 could help accelerate mutations in SARS-CoV-2 following the FDA’s expansion of emergency use authorization, according to a preprint study.
Virology researchers at Austria’s Medical University of Innsbruck found in an analysis of the Pfizer trial little difference in the number of hospitalizations or deaths between placebo and Paxlovid recipients, Just the News reported.
Johns Hopkins medical professor Marty Makary said the study clearly showed that Paxlovid “overuse in low-risk people can breed resistance and spawn new virus mutations,” calling it “risky business.”
